Main Sequence Ventures - CSIRO Innovation Fund

Investor type

VC

Founded

-

AUM

-

Location

Louth, New South Wales, Australia

Investment Ticket

$50-100 m

Investment Stage

Series A Seed Late Stage (Series C+)

Region of investment

North America Australia and others
Investor profile last updated: 18 August, 2026

Profile

Main Sequence Ventures is a deep tech investor based in Sydney, Australia. Founded in collaboration with CSIRO, the firm focuses on translating Australian publicly-funded research into commercial outcomes. The team is composed of experienced investors and industry experts dedicated to tackling significant global challenges through innovation.

Main Sequence Ventures invests in sectors such as space, healthcare, industrial productivity, and food security. They typically invest in early to late-stage companies, with a focus on transformative technologies. The firm manages the CSIRO Innovation Fund, which supports ventures aiming to bridge the gap between research and market application.

Notable investments by Main Sequence Ventures include Cortisonic - a healthcare technology company, Andromeda - a robotics firm, Currus - an industrial productivity startup, Breaker - a space technology company, ElectraLith - a clean energy innovator, and Deteqt - a company focused on advanced perception technologies.

Industry

Security Marketing and Advertising Healthcare Services Food and Beverage Aerospace Industrial CleanTech

Contacts

Name
Title
Email
Upgrade to see contacts
avatar
29vGX3EnUBldiZuM 29vGX3EnUBldiZuM
29vGX3EnUBldiZuM
avatar
29vGX3EnUBldiZuM 29vGX3EnUBldiZuM
29vGX3EnUBldiZuM
avatar
29vGX3EnUBldiZuM 29vGX3EnUBldiZuM
29vGX3EnUBldiZuM
avatar
29vGX3EnUBldiZuM 29vGX3EnUBldiZuM
29vGX3EnUBldiZuM
avatar
29vGX3EnUBldiZuM 29vGX3EnUBldiZuM
29vGX3EnUBldiZuM
Investment-team contacts for Main Sequence Ventures - CSIRO Innovation Fund — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Main Sequence Ventures - CSIRO Innovation Fund

Main Sequence Ventures - CSIRO Innovation Fund is a venture capital firm. It backs companies at Series A, Seed and Late Stage (Series C+), writing tickets of $50-100 m.
Main Sequence Ventures - CSIRO Innovation Fund is located in Louth, New South Wales, Australia.
Main Sequence Ventures - CSIRO Innovation Fund was founded in .
Main Sequence Ventures - CSIRO Innovation Fund invests in companies and startups in Security, Marketing and Advertising, Healthcare Services, Food and Beverage, Aerospace, Industrial, CleanTech.
Main Sequence Ventures - CSIRO Innovation Fund invests in companies and startups in North America, Australia and others.
Main Sequence Ventures - CSIRO Innovation Fund invests in companies and startups at Series A, Seed, Late Stage (Series C+).
Main Sequence Ventures - CSIRO Innovation Fund usually invests $50-100 m on average.
Main Sequence Ventures - CSIRO Innovation Fund can be reached through its website mseq.vc and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Main Sequence Ventures - CSIRO Innovation Fund — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Main Sequence Ventures - CSIRO Innovation Fund directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 18 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.